Open access peer-reviewed chapter

The Effect of CLA on Obesity of Rats:Meta-Analysis

Written By

Sejeong Kook and Kiheon Choi

Submitted: February 23rd, 2011 Reviewed: July 19th, 2011 Published: March 14th, 2012

DOI: 10.5772/27993

Chapter metrics overview

2,012 Chapter Downloads

View Full Metrics

1. Introduction

Obesity is the noticeably fat mass, and an excessive nutrient intake is a cause of that. When the energy in body exceeds healthy limit, the much energy is stored as fat or in fatty tissue. Obesity was accelerated by eating fatty foods, insufficient exercise, and accumulation of stress.

Obesity has come to be recognized as a critical global health issue. Rates of obesity in North America and in most European countries have more than doubled in the last 20 years and over half the adult population are now either overweight or obese (1). According to the report which was released by Korea National Health Insurance Corporation (NHIC) in 2004, the obesity rate for subjects of the survey in 2003 was 56%, and increased in all age groups from 10s to 60s. In addition, the study by Oh et al. in 2005 reported that obesity was strongly associated with risk of some cancers, such as skin, liver, large intestine, thyroid gland, biliary tract, and uterus. It is well known that obesity is one of the causes that generate heart problems, diabetes, and other disorders (2).

Conjugated linoleic acid (CLA) is one of trans fatty acids and found mainly in the meat and dairy products of ruminants (3). CLA has received attention for its antioxidant and anti-cancer properties (4). Studies of CLA show that CLA supplementation tends to reduce body fat, improve serum lipid profiles, and decrease whole-body glucose uptake. However, the results of some studies on rats suggest that CLA supplement was not effective in reducing the fat accumulation (5). Though studies done on CLA have increased, they do not all show uniform results, showing it is necessary to summarize and analyze them.

Meta-analysis is a tool for summarizing the results of studies with related research hypotheses. It has three steps; deciding the association measure for detecting difference between groups, summarizing the association measure in assumed model, and identifying publication bias. The association measures in meta-analysis are the measure of related effects from the primary research such as the standardized mean difference, the mean difference, the risk difference, and an odds ratio. The decided measure is combined using only within variation of studies on the assumption that the results are homogeneity and uniformly distributed, and then it is tested on whether the homogeneity assumption is plausible. If the results are heterogeneity, the measure is recombined using within variation with the estimated the between variations of the studies. The former model is called the fixed effect model and the latter is the random effect model. Because significant results are more likely to be submitted or accepted than insignificant ones and the combined estimates are calculated by only published researches, the bias easily occurs in a small number of studies and is called the publication bias. If the publication bias is doubtable, the combined estimate is adjusted or the additional studies are required (6, 7).

The purpose of this study was to summarize the studies about effect of CLA on factors related to the anti-obesity in experimental rats by meta-analysis.


2. Method

2.1. Preparation of dataset for meta-analysis

The studies used in this meta-analysis were searched on the ScienceDirect in English, the DBpia database, and the KISS (Koreanstudies Information Service System) in Korean. The search keywords used were CLA, weight, health, or fat and the research was limited to the experimental rat studies. About 50 studies were collected and 12 studies were finally selected after omitting some studies with insufficient information, such as no sample variance or no sample size (5, 8-18).

The factors used to investigate the effect of CLA were collected from target studies, if it was studied in at least 2 studies. The selected factors were body fat (%), epididymal fat (g/100g), fat cell size (μm), final body weight (g), food intake (g/d), leptin (pg/ml), liver-TC (mg/g), liver-TG (mg/g), plasma-TC (mg/dl), plasma-TG (mg/dl), and weight gain (g/d). The unit of each factor was uniformly changed.

In each study, there were two groups. One group of rats was treated with fat source such as beef tallow, coconut oil, corn oil, fish oil, safflower oil or soybean oil (FR), and the other group of rats was treated with fat source supplemented with CLA (FRC). Because the size of studies after grouping by treated fat source was not enough large, the each fat source has similar effect on obesity.

2.2. Measure and models for combining

Since the mean difference between FR and FRC was used for test on anti-obesity effect of CLA, the association measure was decided as the mean difference (MD) of each factor; mean of FRC minus mean of FR. The combined MD of each factor was calculated by the inverse variance method and the mean weighted by inverse variance in the primary studies. If the homogeneity was accepted by Cochran’s Q test, it is assumed that the effect measured in the study population has a single value. The association measure is estimated by using a variation within the studies in the fixed effect model. To reduce the bias caused by heterogeneity, meta-regression models are used to analyze association between treatment effects and study characteristics. The period and amount of CLA supplementation were considered as covariates, and the estimated coefficients of covariates were investigated for possible sources of heterogeneity. If the homogeneity was rejected, the combined MDs of studies were calculated in random effect model in which total variation defined the variation within studies with estimated variation between studies.

2.3. Identification the publication bias

The existence of publication bias was checked by using a funnel plot or Egger’s linear regression test. The funnel plot was a scatter plot of the association measure against a inverse of standard error of measure. If the shape of funnel plot about any factor is not funnel or cone around the combined MD, the publication bias was doubtable. Egger’s linear regression test was used to test the null hypothesis that the funnel plot was not asymmetry. Egger’s linear regression is a linear regression of standard normal deviate (defined as association measure over SE) against the inverse of SE, and there may be publication bias if the estimated intercept is significantly different from 0. A positive intercept indicates that more studies are associated with a bigger effect (19).

2.4. Software used for the meta-analysis

Version 1.5 of MIX program was used for combining MDs, plotting the funnel plots and checking the publication bias. The STATA program was used for meta-regression.


3. Result

3.1. Combined mean difference and homogeneity test of studies (Fat/Weight/Plasma/Liver)

The combined MDs between FR and FRC were presented with p-value to test heterogeneity of results in Table 1. In the fixed effect model, the MDs were significantly different from 0 for body fat, final body weight, liver-TC, plasma-TC, plasma-TG and weight gain (<0.05). Especially the p-values tested for body fat, final body weight, and weight gain were less than 0.01, showing CLA significantly decreased the level of each of them.

Fixed effect model a)Heterogeneity b)Random effect model a)
estimatep-value c)p-valueestimatep-value
Body fat(%)-1.2504<0.0001<0.0001-1.12390.1020
Epididymal fat (g/100g)-0.01310.6988<0.0001-0.04700.4512
Fat cell size(μm)-0.60880.47070.4213-0.60880.4770
Final body weight(g)-3.59220.0004<0.0001-3.31140.3941
Food intake(g/d)-0.16390.11900.1829-0.22350.2634
Weight gain(g/d)-0.5377<0.0001<0.0001-0.15610.5062

Table 1.

Combined MDs and Homogeneity test in fixed effect model and random effect model. a)

The fixed effect model was inadequate in terms of body fat, epididymal fat, final body weight, liver-TC, liver-TG, plasma-TC, plasma-TG and weight gain, because of the heterogeneity of studies for them (p-value<0.05). The MD about heterogeneity factor was regressed against two covariates, amount and period of CLA supplementation, by meta-regression method in Table 2. Only the MD of the final body weight was significantly correlated with the period of CLA supplementation (p-value <0.05), and the coefficient of period was estimated -0.0698. That meant the MD of the final body weight was estimated to decrease by 0.0698 per unit increase in the period.

The random effect model was used to combine MD on heterogeneity factors; body fat, epididymal fat, final body weight, liver-TC, liver-TG, plasma-TC, plasma-TG, and weight gain. The value of the MD of plasma-TC was significantly negative, but the value of the MD of other factors was not negative.

Factor(unit)InterceptCoefficient of amountCoefficient of period
Body fat(%)-0.1278-1.94230.0038
Epididymal fat(g/100g)0.0203-0.3859-0.0003
Final body weight(g)1.70304.5770-0.0698 b)
Weight gain(g/d)-0.0165-0.09140.0004
a) If it is found to be hetero in the effect of treatment between studies, then meta-regression can be used to analyze associations between treatment effect and covariates in study.
b) The estimated coefficient of period was significantly efficient to combined mean difference about final body weight between the FR and the FRC(p-value <0.05), thus the MD of final body weight is estimated to decrease by 0.0698 per unit increase in the period.

Table 2.

Estimated intercept and coefficient of covariates in meta-regression.

Factor(unit)Egger’s linear regression
Intercept a)p-value b)
Body fat(%)14.17190.3649
Epididymal fat(g/100g)-1.58640.0756
Fat cell size(μm)1.52840.5107
Final body weight(g)-0.04710.9677
Food intake(g/d)-0.13820.7718
Weight gain(g/d)3.14440.5980
a) The data were expressed the intercept of Egger’s linear regression about factors.
b) The expressed p-values were for testing that the estimated intercept is not significantly different with 0. If the p-value is less than 0.05, the combined MD in Table 1 possibly exist the publication bias, and the additional analysis is required.

Table 3.

Estimated intercepts and p-values of Egger’s linear regression test.

3.2. Publication bias

To check the publication of the funnel plot expressed in Table 4, 5, 6. The funnel plots of fat cell size, food intake, leptine and plasma-TG were checked in the fixed effect model due to the homogeneity. The dots of fat cell size and the dots of leptine were not symmetric by combined MD (solid line), so the publication biases were doubtable. The dots of factors in the random effect model were symmetric by solid line, thus the publication bias were ignorable. Since the intercepts of Egger’s linear regression by factors in Table 3 were not significant (p-value >0.05), the funnel plot on each factor was symmetric and the publication bias was ignorable.

FactorFixed effect modelRandom effect model
Body fat
Fat cell size
Final body

Table 4.

Funnel plot: In fixed effect model and random effect model.

FactorFixed effect modelRandom effect model
Food intake

Table 5.

Funnel plot: In fixed effect model and random effect model (Continuation).

FactorFixed effect modelRandom effect model
Weight gain

Table 6.

Funnel plot: In fixed effect model and random effect model (Continuation).


4. Discussion

4.1. The effects of CLA on the fat depositions

The factors related with fat deposition were body fat and epididymal fat, and our study showed that CLA supplement did not affect the fat deposition. The results of studies on body fat and epididymal fat were significantly heterogeneous. In fixed effect model, body fat was significantly affected by CLA. Under the heterogeneity of studies on body fat, the effect of CLA was not significant in random effect model. We could not check the condition of energy expenditure, and that was one of reasons for explaining about heterogeneity.

4.2. The effects of CLA on the weights of body

The results of studies done on the final body weight and weight gain were very heterogeneous (p-value < 0.001), and the result of efficiency test of CLA in fixed effect model differed from one in random effect model. This situation happened due to extreme one of combined results. The extremely negative MD had a small standard error, so the high influence of them on combination made significantly negative value in fixed effect model but not in random effect model. After omitting the extreme value in analysis, the homogeneities results on final body weight and weight gain were accepted (p-value >0.05), and the effects of CLA on them were not significant.

4.3. The effects of CLA on the plasma lipid

The level of plasma-TC was significantly decreased in FR than in FRC regardless of the homogeneity of the factors. Only in fixed effect model, the level of plasma-TG was significantly decreased in FR. According to Hwang and Kang, the reduction effect of CLA on plasma-TG was significant in the case rats that ware fed with beef tallow for 1 and 4 weeks and in the case rats that was fed with fish oil only for 4 weeks (20). The anti-obesity effect of CLA was assured like Hwang and Kang’s study.


5. Conclusion

In this study, the researchers studied about effect of CLA on factors, such as body fat (%), epididymal fat (g/100g), fat cell size (μm), final body weight (g), food intake (g/d), leptin (pg/ml), liver-TC (mg/g), liver-TG (mg/g), plasma-TC (mg/dl), plasma-TG (mg/dl), and weight gain (g/d). The CLA supplement was significantly effective on reduction of body fat (%), final body weight (g), liver-TC (mg/g), plasma-TC (mg/dl), plasma-TG (mg/dl), and weight gain (g/d) with homogeneity assumption between studies. However, only plasma-TG was significantly decreased with the random effect model on heterogeneity factors. Further study should focus on what the effect of CLA depend on fat source.



This work was supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology(2010-0029692).


  1. 1. al.2003Metabolic effects of dietary conjugated linoleic acid (CLA) isomers in rats.Nutritional Research, 23,16911701
  2. 2. AndreoliM.ScalerandiM.BorelI.BernalC.2007Effects of CLA at different dietary fat levels on the nutritional status of rats during protein repletion.Nutritional,23,827835
  3. 3. BeluryM. A.2002Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action.Journal of Nutrition. 132,29952998
  4. 4. ChinS. F.StorksonJ. M.LiuW.AlbrightK. J.ParizaM. W.1994Conjugated linoleic acid(9,11- and 10, 12-octadecadienoic acid) is produced in conventional but germ-free rats fed linoleic.J Nutr,124,694701
  5. 5. ChoiK.KookS.2007Meta-analysis using program MIX. Free Academy, Seoul
  6. 6. CholN.WonD.YunS.JungM.ShinH.2004Selectively hydrogenated soybean oil with conjugated linoleic acid modifies body composition and plasma lipids in rats.Journal of Nutritional biochemistry,15,411417
  7. 7. HwangT. H.KangK. J.2005The time course effects of conjugated linoleic acids on body weight, adipose depots and lipid profiles in the male ICR mice fed different fat sources.The Korean Nutrition Society, 8,205211
  8. 8. HalfordJason C. G.2006Pharmacotherapy for obesity.Appetite, 46,610
  9. 9. John Wiley & SonsSuttonA.AbramsK.JonesD.SheldonT.SongF.2000Methods for Meta-Analysis in Medical Research. Wiley
  10. 10. KangK. J.KimK. H.ParkH. S.2002Dietary Conjugated Linoleic Acid did not Affect on Body Fatness, Fat Cell Sizes and Leptin Levels in Male Sprague Dawley Rats. Nutritional Sciences, 5,117122
  11. 11. KangK. J.ParkH. S.2001Effects of Conjugated Linoleic Acid Supplementation on Fat Accumulation and Degradation in Rats. The Korean Nutrition Society, 34(4),367374
  12. 12. KlossR.LinscheidK.MarkK.2005Effects of conjugated linoleic acid supplementation on blood lipids and adiposity of rats fed diets rich in saturated versus unsaturated fat.Pharmacological Research, 51,503507
  13. 13. LeonhartM.MunchS.Westerterp-PlantengaM.LanghansW.2004Effects of hydroxycitrate, conjugated linoleic acid, and guar gum on food intake, body weight regain, and metabolism after body weight loss in male rats.Nutrition Research, 24,659669
  14. 14. OhS. W.YoonW. S.ShinS. A.2005Effect of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea national health insurance corporation study. Journal of Clinical Oncology, 23, 00.47424754
  15. 15. ParkY.AlbrightK.ParizaM.2005Effects of conjugated linoleic acid on long term feeding in Fischer 344 rats.Food and Chemical Toxicology, 43,12731279
  16. 16. PurushothamA.ShrodeG.WendelA.LiuL.BeluryM.2007Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.Journal of Nutritional Biochemistry, 18,676684
  17. 17. RahmanS.HudaM.UddinM.2002Akhteruzzaman, S. Short-term Administration of Conjugated Linoleic Acid Reduces Liver Triglyceride Concentration and Phosphatidate Phosphohydrolase Activity in OLETF Rats.Journal of Biochemistry and Molecular Biology, 35,494497
  18. 18. RothsteinH.SuttonA.BorensteinM.2005Publication bias in meta-analysis.
  19. 19. TsuzukiT.KawakamiY.NakagawaK.MiyazawaT.2006Conjugated docosahexaenoic acid inhibits lipid accumulation in rats.Journal of Nutritional Biochemistry, 17,518524
  20. 20. WestD. B.DelanyJ. P.CametP. M.BlohmF.TruettA. A.ScimecaJ.1998Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse.Am J Physiol, 44,667672
  21. 21. YamasakiM.IkedaA.OjiM.TanakaO.HiraoA.KasaiM.IwataT.TachibanaH.YamadaK.2003Modulation of Body Fat and Serum Leptin Levels by Dietary Conjugated Linoleic Acid in Sprague-Dawley Rats Fed Various Fat-Level Diets.Nutrition, 19,3035

Written By

Sejeong Kook and Kiheon Choi

Submitted: February 23rd, 2011 Reviewed: July 19th, 2011 Published: March 14th, 2012